Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Vitro Diagnostics (VODG) had Return on Investments of 14.88% for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
$0.51M |
|
$-1.48M |
|
$0.13M |
|
$0.38M |
|
$1.59M |
|
$-1.08M |
|
$-0.40M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.08M |
|
$-0.68M |
|
4.46M |
|
4.46M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$0.60M |
|
$0.08M |
|
$3.98M |
|
$4.58M |
|
$13.90M |
|
$1.13M |
|
$1.74M |
|
$15.64M |
|
$-11.07M |
|
$-14.67M |
|
$-11.07M |
|
4.46M |
|
| Cash Flow Statement Financials | |
$-1.12M |
|
$-0.00M |
|
$0.75M |
|
$0.57M |
|
$0.20M |
|
$-0.37M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.11 |
|
-0.42 |
|
73.65% |
|
-211.56% |
|
-211.56% |
|
-- |
|
-289.06% |
|
-289.06% |
|
$-1.12M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.81 |
|
3.86 |
|
23.29 |
|
13.36% |
|
10.08% |
|
-32.32% |
|
|
Return on Investments |
14.88% |
$-2.48 |
|
$-0.25 |
|
$-0.25 |
|